AI assistant
Iterum Therapeutics plc — Director's Dealing 2018
May 25, 2018
34796_dirs_2018-05-24_cd5e1a17-04dc-48ec-8371-d267dfba455d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Iterum Therapeutics plc (ITRM)
CIK: 0001659323
Period of Report: 2018-05-24
Reporting Person: Matthews Judith M. (Chief Financial Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Ordinary Shares | 35646 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Series A Preferred Shares | $ | Ordinary Shares (10980) | Direct | ||
| Series B-1 Preferred Shares | $ | Ordinary Shares (3038) | Direct | ||
| Series B-2 Preferred Shares | $ | Ordinary Shares (2466) | Direct | ||
| Stock Option (Right to Buy) | $3.30 | 2027-09-11 | Ordinary Shares (11882) | Direct |
Footnotes
F1: The Series A Preferred Shares are convertible into Ordinary Shares of the Issuer at the option of the holder. The Series A Preferred Shares will automatically convert into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer.
F2: Not applicable.
F3: The Series B-1 Preferred Shares are convertible into Ordinary Shares of the Issuer at the option of the holder. The Series B-1 Preferred Shares will automatically convert into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer.
F4: The Series B-2 Preferred Shares are convertible into Ordinary Shares of the Issuer at the option of the holder. The Series B-2 Preferred Shares will automatically convert into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer.
F5: The shares subject to this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of September 12, 2017 (the "Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the Vesting Commencement Date thereafter for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the Vesting Commencement Date.